Advanced Head and Neck Squamous Cell Carcinoma Clinical Trials in Ann Arbor, Michigan
2 recruitingAnn Arbor, Michigan
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
AstraZeneca1,145 enrolled305 locationsNCT06129864
Recruiting
Phase 2
Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer
Advanced Head and Neck Squamous Cell CarcinomaResectable Head and Neck Squamous Cell CarcinomaStage II Head and Neck Cutaneous Squamous Cell Carcinoma+2 more
University of Michigan Rogel Cancer Center28 enrolled1 locationNCT07094685